Practice Current
Variability in Smoking Cessation Intervention Practice Patterns After Ischemic Stroke and Transient Ischemic Attack
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 18, 2022
- Accepted October 12, 2022
- First Published January 17, 2023.
- Aravind Ganesh [MD, DPhil, FRCPC]
Author Disclosures
- Neal S. Parikh, MD, MS,
- Daniel Restifo, MS,
- Aravind Ganesh, MD, DPhil, FRCPC and
- Hooman Kamel, MD, MS
- Neal S. Parikh, MD, MS,
None
NONE
None
Stroke, Editorial Board member, 2019
NONE
NONE
NONE
NONE
NONE
Medicolegal consulting/expert witness work.
NONE
NONE
NIH/NIA K23AG073524, PI, 2021-2026; New York State Empire <br>Clinical Research Investigator Program, <br>Fellow, 2020-2021.
NONE
Leon Levy Foundation Fellowship in Neuroscience; Florence <br>Gould Foundation Endowment for Discovery in Stroke.
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel Restifo, MS,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Aravind Ganesh, MD, DPhil, FRCPC and
None
NONE
(1) University of Calgary Post-Graduate Medical Education <br>(PGME): travel funding for conferences<br>(2) American Academy of Neurology: Futures in Neurological <br>Research award, resident scholarships, International <br>Scholar award<br>(3) Alexion: honoraria for educational presentation
(1) Neurology Editorial Board, Disputes and Debates, 2018-<br>Present<br>(2) Neurology: Clinical Practice Editorial Board, Practice <br>Current, 2019-Present<br>(3) Stroke, Editorial Board Member, 2019-present<br>(4) Frontiers in Neurology, Editorial Board Member, 2021
Patent application (US 17/317,771) for a system <br>for patient monitoring and delivery of remote ischemic <br>conditioning or other cuff-based therapies.
NONE
NONE
(1) MD Analytics: honoraria for research consultation<br>(2) My Medical Panel: honoraria for research consultation<br>(3) DeepBench: honoraria for research consultation<br>(4) Research On Mind: honoraria for research consultation<br>(5) Figure 1: honoraria for educational consultation<br>(6) CTC Communications Corporation: honoraria for <br>educational consultation<br>(7) Atheneum: honoraria for research consultation<br>(8) Biogen: honoraria for educational consultation
NONE
NONE
NONE
NONE
Government of Canada INOVAIT program, PI, 2021-2022
NONE
(1) Alberta Innovates<br>(2) Canadian Institutes of Health Research<br>(3) Canadian Cardiovascular Society<br>(4) Campus Alberta Neuroscience<br>(5) New Frontiers in Research Fund
(1) SnapDx Inc.<br>(2) TheRounds.com<br>(3) Advanced Health Analytics (AHA Health Ltd)
NONE
NONE
NONE
NONE
NONE
- Hooman Kamel, MD, MS
None
NONE
None
(1) Journal Watch Neurology, Associate Editor, 2011-2016.<br>(2) PLOS One, Academic Editor, 2013-2016<br>(3) Scientific Reports, Editorial Board Member, 2014-<br>2016.<br>(4) JAMA Neurology, Deputy Editor, 2017-current.
NONE
NONE
NONE
Has served on a one-time advisory board for Roivant <br>Sciences related to Factor XI inhibition (2018).
(1) Speakers bureau for Genentech, Inc., 2012-2016
(1) Steering Committee of Medtronic's Stroke AF trial <br>(uncompensated).<br>(2) Stroke endpoint adjudication committee for diabetes-<br>related drug for Boehringer-Ingelheim.<br>(3) Executive Committee for a Janssen trial.
NONE
Dr. Kamel serves as co-PI for the NIH-funded ARCADIA <br>trial (NINDS U01NS095869) which receives in-kind study <br>drug from the BMS-Pfizer Alliance for Eliquis® and <br>ancillary study support from Roche Diagnostics.
(1) NIH/NINDS, K23NS082367, 2013-current.<br>(2) NIH/NINDS, R01NS097443, 2016-2021.<br>(3) NIH/NINDS, U01NS095869, 2016-current.<br>(4) NIH/NINDS, R01HL144541, 2019-current.
Dr. Kamel serves as a PI for the NIH-funded ARCADIA trial <br>(NINDS U01NS095869), which receives in-kind study drug from <br>the BMS-Pfizer Alliance for Eliquis® and ancillary study <br>support from Roche Diagnostics; as Deputy Editor for JAMA <br>Neurology; on clinical trial steering/executive committees <br>for Medtronic, Janssen, and Javelin Medical; and on endpoint <br>adjudication committees for Novo Nordisk and Boehringer <br>Ingelheim.
(1) Michael Goldberg Stroke Research Fund, 2014
NONE
NONE
NONE
NONE
NONE
NONE
- Clinical and Translational Neuroscience Unit (NSP, DR, HK), Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York City; and Department of Clinical Neurosciences (AG), University of Calgary, Alberta, Canada.
- Correspondence
Dr. Parikh nsp2001{at}med.cornell.edu
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.